Recruiting
RESISTance Exercise for Depression Trial
Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.
ClinicalTrials.gov IDNCT06110897
PhaseNA
Enrollment200
SponsorUniversity of Wisconsin, Madison
Age18 Years
SexALL
Conditions studied
Major Depressive Disorder
About this study
Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.
Interventions
- Behavioral: High Dose Resistance Exercise Training — Progressive resistance exercise training
- Behavioral: Low Dose Resistance Exercise Training Group — Progressive resistance exercise training
Primary outcomes
- Change in depressive symptom severity measured by GRID Hamilton Depression Rating Scale (GRID-HAM-D) (Weeks 0, 8, 16, 26, 52)
- Change in self-reported depression symptom severity measured by Quick Inventory of Depressive Symptoms (QIDS) (Weeks 0, 1-16 (once per week across the intervention), 26, 52)
- Cerebral mean blood velocity (Weeks 0, 8, 16, 26, 52)
- Cerebral blood velocity pulsatility (Weeks 0, 8, 16, 26, 52)
Eligibility information
Inclusion Criteria:
* Be diagnosed with DSM-5 MDD, confirmed via Structured Clinical Interview for DSM-5 (SCID).
* Have current depressive symptoms of at least mild severity defined by the Hamilton Rating Scale of Depression 17 greater than or equal to 8 (HAMD; using the GRID-HAMD evaluated by trained, masked raters)
* Be ages 18-65
* EITHER not taking any mental health medications or seeking other mental health treatment (e.g., behavioral, psychological) OR be on a stable mental health medication and/or treatment regimen for the past 8 weeks, and intend to maintain that regimen for the duration of the study
* Safe to exercise based on physical activity screening questions or physician clearance
* Willing to be randomized to either condition
* have a Smartphone
Exclusion Criteria:
* Currently pregnant, nursing, or planning to become pregnant during the trial
* Class III+ obesity
* Diagnosed with lifetime or current Psychosis, Mania, or Bipolar Disorder, via the SCID
* Diagnosed with current Substance Use Disorder, via the SCID
* Active suicidal ideation with specific plan and intent ('5' score on Suicidal Ideation from Columbia Suicide Severity Rating Scale), which would necessitate immediate emergent care
* Exhibit behavioral disturbance (e.g., aggression, mild-moderate cognitive impairment) that would significantly interfere with study participation, as assessed by clinical research personnel
* Currently meets resistance exercise recommendations (2 days per week) for the last 8 weeks
* Self-reporting a concussion/traumatic brain injury within the last 3 months
* Having cardiovascular disease, uncontrolled hypertension, or uncontrolled diabetes
Study locations
- Iowa State University, Ames, Iowa 50010 United States
- University of Wisconsin - Madison, Madison, Wisconsin 53705 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.